FXAIX
Price
$183.49
Change
+$0.25 (+0.14%)
Updated
Apr 17 closing price
Net Assets
597.55B
IOAPX
Price
$24.27
Change
-$0.02 (-0.08%)
Updated
Apr 17 closing price
Net Assets
1.33B
Ad is loading...

FXAIX vs IOAPX

Header iconFXAIX vs IOAPX Comparison
Open Charts FXAIX vs IOAPXBanner chart's image
Fidelity 500 Index
Price$183.49
Change+$0.25 (+0.14%)
VolumeN/A
Net Assets597.55B
Invesco Main Street All Cap R6
Price$24.27
Change-$0.02 (-0.08%)
VolumeN/A
Net Assets1.33B
FXAIX vs IOAPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FXAIX vs. IOAPX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FXAIX is a Buy and IOAPX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FXAIX has more cash in the bank: 598B vs. IOAPX (1.33B). FXAIX pays higher dividends than IOAPX: FXAIX (1.30) vs IOAPX (0.82). FXAIX was incepted earlier than IOAPX: FXAIX (14 years) vs IOAPX (6 years). IOAPX (0.73) is less costly to investors than FXAIX (0.01). IOAPX is a more actively managed with annual turnover of: 54.00 vs. FXAIX (2.00). FXAIX has a lower initial minimum investment than IOAPX: FXAIX (0) vs IOAPX (1000000). FXAIX annual gain was more profitable for investors over the last year : 6.45 vs. IOAPX (-0.48). FXAIX return over 5 years is better than : 98.09 vs. IOAPX (46.02).
FXAIXIOAPXFXAIX / IOAPX
Total Expense Ratio0.010.732%
Annual Report Gross Expense Ratio0.010.732%
Fund Existence14 years6 years-
Gain YTD-9.974-7.909126%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets598B1.33B45,030%
Annual Yield % from dividends1.300.82159%
Returns for 1 year6.45-0.48-1,347%
Returns for 3 years25.769.15281%
Returns for 5 years98.0946.02213%
Returns for 10 years174.86N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESCA14.820.27
+1.86%
Escalade
SABS1.390.01
+0.72%
SAB Biotherapeutics
PLXS121.92-0.26
-0.21%
Plexus Corp
CE37.53-0.40
-1.05%
Celanese Corp
ENFN10.80-0.12
-1.10%
Enfusion